The Connecticut Bleeding Disorders Center
The Connecticut Bleeding Disorders Center is one of the premier resources in the state for information about and treatment of hemophilia and other bleeding and clotting disorders. Our center offers the latest in care for patients with these rare disorders and conducts research and clinical studies to advance the treatment of these diseases. It operates, in part, thanks to a generous donation from The Lea’s Foundation Center for Hematologic Disorders, a prominent Hartford nonprofit that provides support for blood cancer research efforts to the Neag Comprehensive Cancer Center.
Staff members include hematologists, nurse specialists, physical therapists, social workers, dentists, orthopedic surgeons, and genetic counselors. Our mission is to provide comprehensive medical and mental health support services to all persons with hemophilia and other congenital coagulation disorders. The Center has participated with the national network of 129 hemophilia treatment centers in implementing a national database system that is utilized for research of rare blood disorders, evaluation of clinical outcomes, and development of national standards of care.
Services include diagnosis and treatment of patients with blood cancers such as lymphoma, leukemia, myeloproliferative disorders, myelodysplastic disorders, multiple myeloma, and others, and non-cancerous blood diseases, including low red blood cell count or anemia, low white blood cell count or leukopenia, and low platelet count or thrombocytopenia as well as sickle cell diseases, disorders of bleeding or thrombosis.
Connecticut Bleeding Disorders Center
This federally funded program offers multidisciplinary care to individuals with hemophilia, von Willebrand's disease, other bleeding disorders, and disorders of thrombosis (abnormal blood clotting).
Many blood disorders are the focus of laboratory investigation at the UConn School of Medicine. In some instances, our physician-scientists are collaborating with basic scientists in what is known as translational research – the application of basic science research to patient care. Some areas of ongoing research include:
- The role of heat shock proteins in multiple myeloma biology
- The role of cell signaling (SH2 profiling) in hematologic cancers
- Phosphodiesterases in leukemia resistance
- Sickle cell disease and immune function
- Inflammation and hemostasis
- Lymphoma, Hodgkin
- Lymphoma, Non-Hodgkin
- Lymphoma, Primary Central Nervous System